Randomized Study of Fluoxetine in Children and Adolescents With Autism
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Evaluate the efficacy of fluoxetine on social and language deficits, global
severity and compulsive dimensions of children and adolescents with autism.
II. Assess the effectiveness of this treatment regimen on neurocognitive deficits in this
patient population.
III. Compare the baseline compulsive severity and treatment outcome in these patients.